To include your compound in the COVID-19 Resource Center, submit it here.

NIH, industry in cancer immunotherapy partnership

On Thursday, NIH and 11 biopharma companies launched the Partnership for Accelerating Cancer Therapies (PACT), a $215 million public-private partnership designed to identify, validate and standardize biomarkers for cancer immunotherapies.

While immunotherapies have been highly successful in certain cancers such

Read the full 405 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers